Eugene Conte, DO
Dermatology · Centerville, OHNPI 1316056567
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $167,603 of the $226,288 with a category attached, or 74.1%. 25 manufacturers reported payments, led by Lilly USA, LLC at 31.9% of the total. Reporting peaked in 2019 at $161,554 and has fallen 99.7% since, to $424 in 2025. Among dermatology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 578 payments — averaging $391.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$72K
- Bristol Myers Squibb$46K
- Amgen$41K
- AbbVie$41K
- Novartis$20K
- Pfizer$4K
- plus $2K from 19 others
What the payments were for
- Consulting fees$12,1435%
- Speaking & faculty fees$167,60374%
- Travel & lodging$37,11016%
- Food & beverage$8,9874%
- Education$4460%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 163 | $72,078 |
| Bristol Myers Squibb | 47 | $46,313 |
| Amgen | 62 | $41,436 |
| AbbVie | 150 | $40,883 |
| Novartis | 106 | $20,351 |
| Pfizer | 3 | $3,556 |
| Johnson & Johnson | 10 | $559 |
| Sanofi | 9 | $283 |
| UCB, Inc. | 3 | $150 |
| Arcutis Biotherapeutics, Inc. | 2 | $138 |
| Dermira, Inc. | 1 | $97 |
| Sun Pharmaceutical Industries Inc. | 4 | $80 |
| LEO Pharma Inc. | 3 | $54 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $48 |
| Almirall LLC | 2 | $41 |
| Galderma Laboratories, L.p. | 2 | $36 |
| Regeneron Healthcare Solutions, Inc. | 2 | $35 |
| VYNE Pharmaceuticals Inc. | 1 | $26 |
| E.r. Squibb & Sons, L.L.C. | 1 | $24 |
| Medimetriks Pharmaceuticals, Inc. | 1 | $19 |
| Hill Dermaceuticals, Inc. | 1 | $17 |
| DUSA Pharmaceuticals, Inc. | 1 | $17 |
| Incyte Corporation | 1 | $16 |
| Mayne Pharma Commercial LLC | 1 | $15 |
| Encore Dermatology Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$226,288 in reported general payments places this provider in the 95th percentile of 460 dermatology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 28 | $1,768 |
| Ketoconazole | 53 | $915 |
| Dapsone | 15 | $826 |
| Minocycline Hcl | 27 | $781 |
| Fluocinonide | 14 | $726 |
| Famciclovir | 12 | $615 |
| Clobetasol Propionate | 18 | $481 |
| Triamcinolone Acetonide | 26 | $123 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Centerville
- Karl KellawanCenterville$23K
- Barbara CortezCenterville$21K
- Matthew ZirwasBexley$3.3M
- George DrewMarion$1.9M
- Rocco SerraoDayton$1.7M
- James LibeccoFairlawn$1.1M
- Pranav ShethWest Chester$978K
- Dawn MerrittAthens$844K
- Neil KormanCleveland$824K
- Joshua GrosshandlerWesterville$479K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.